Literature DB >> 15490430

Bootstrap confidence intervals for medical costs with censored observations.

Hongyu Jiang1, Xiao-Hua Zhou.   

Abstract

Medical costs data with administratively censored observations often arise in cost-effectiveness studies of treatments for life-threatening diseases. Mean of medical costs incurred from the start of a treatment until death or a certain time point after the implementation of treatment is frequently of interest. In many situations, due to the skewed nature of the cost distribution and non-uniform rate of cost accumulation over time, the currently available normal approximation confidence interval has poor coverage accuracy. In this paper, we propose a bootstrap confidence interval for the mean of medical costs with censored observations. In simulation studies, we show that the proposed bootstrap confidence interval had much better coverage accuracy than the normal approximation one when medical costs had a skewed distribution. When there is light censoring on medical costs (< or =25 per cent), we found that the bootstrap confidence interval based on the simple weighted estimator is preferred due to its simplicity and good coverage accuracy. For heavily censored cost data (censoring rate > or =30 per cent) with larger sample sizes (n > or =200), the bootstrap confidence intervals based on the partitioned estimator has superior performance in terms of both efficiency and coverage accuracy. We also illustrate the use of our methods in a real example. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490430     DOI: 10.1002/sim.1556

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs.

Authors:  Shuai Chen; Hongwei Zhao
Journal:  Biostatistics       Date:  2013-02-19       Impact factor: 5.899

2.  Efficiency and outcomes of harmonic device in transanal endoscopic microsurgery compared with monopolar scalpel.

Authors:  J A Gracia; J M Ramirez; D Callejo; M Elia; S Maeso; V Aguilella; M Martinez
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

3.  Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.

Authors:  Jiaqi Li; Elizabeth Handorf; Justin Bekelman; Nandita Mitra
Journal:  Stat Med       Date:  2015-12-17       Impact factor: 2.373

4.  Key Design Considerations When Calculating Cost Savings for Population Health Management Programs in an Observational Setting.

Authors:  Shannon M E Murphy; Douglas E Hough; Martha L Sylvia; Linda J Dunbar; Kevin D Frick
Journal:  Health Serv Res       Date:  2018-02-08       Impact factor: 3.402

5.  Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan.

Authors:  Der-Yuan Chen; Fun Yu; Li-Wen Tuan; Chao-Hsiun Tang
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.